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Novel Chlamydia species isolated 
from snakes are temperature-
sensitive and exhibit decreased 
susceptibility to azithromycin
Eveline Staub1, Hanna Marti1, Roberta Biondi2, Aurora Levi2, Manuela Donati2, Cory Ann 
Leonard1, Serej D. Ley1,5, Trestan Pillonel  3, Gilbert Greub  3, Helena M. B. Seth-Smith1,4,6  
& Nicole Borel1
Chlamydia species have recently been recognized as emerging pathogens in snakes. However, isolation 
of novel snake chlamydiae is critical and their growth characteristics are largely unknown. In this study, 
two novel chlamydial species are described: Chlamydia serpentis and Chlamydia poikilothermis, isolated 
after attempts on 23 cloacal and choanal swabs from 18 PCR-positive captive snakes originating from 
different Swiss snake collections. Isolation success, growth curve and infectivity rates over a 48-hour 
time period were dependent on temperature (37 °C for C. serpentis, 28 °C for C. poikilothermis). C. 
serpentis and C. poikilothermis were sensitive to tetracycline and moxifloxacin during evaluation by in 
vitro antibiotic susceptibility assay but intermediate to resistant (2–4 μg/ml) to azithromycin. Whole 
genome sequencing of the isolates provided proof of the novel species status, and gives insights into 
the evolution of these branches of genus Chlamydia.
Bacteria within the order Chlamydiales are biologically unique, obligate intracellular pathogens affecting humans, 
wild and domesticated mammals and reptiles, comprising to date nine families (reviewed in)1. Diseases and 
complications caused can include late abortions, infertility, trachoma and pneumonia. Chlamydiosis has been 
detected in both free-ranging and captive reptiles, causing granulomatous lesions in inner organs2–5, prolifera-
tive pneumonia6,7, necrotizing enteritis or myocarditis8, hepatitis and conjunctivitis9,10 or remaining asympto-
matic7,11,12. Chlamydia pneumoniae, which was initially described as a human respiratory pathogen, is the most 
commonly reported etiological agent in reptilian Chlamydiosis13.
Recent reports indicate that snakes may harbour a significant level of diverse and uncharacterised novel 
chlamydial species, in addition to Chlamydia-like organisms (CLOs)5. Through near-full length chlamydial 16S 
rRNA gene sequencing from 21 choanal or cloacal swab samples, C. pneumoniae strains were identified as well 
as seven novel 16S rRNA genotypes, giving the first indication of the presence of potentially novel Chlamydia 
species in snakes11. Culture-independent full genome sequencing of genomic DNA obtained from the choana 
of a captive, clinically inapparent Madagascar tree boa (Sanzinia madagascariensis volontany) revealed the novel 
Candidatus species Chlamydia sanzinia14 and similarly Candidatus Chlamydia corallus from the choana of a cap-
tive Amazon basin emerald tree boa (Corallus batesii)15. These two new genomes show that both species fall in a 
phylogenetic clade with C. pneumoniae and C. pecorum. However, the availability of sample material and the lack 
of suited in vitro culture systems are challenges to further characterization of novel chlamydial strains.
This study used in vitro culture of snake cloacal and choanal swabs with eukaryotic host cells at two tempera-
tures (28 °C and 37 °C, considering the variable body temperatures of poikilothermic snake hosts) to isolate four 
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strains belonging to two new chlamydial species: Chlamydia serpentis and Chlamydia poikilothermis. We have 
characterised these both phenotypically and through whole genome sequencing (WGS) and present the 12th and 
13th species within the family Chlamydiaceae.
Results
Detection and isolation of chlamydiae in captive snakes. By real-time PCR, 23 swab samples from 
18 individual snakes were positive for Chlamydiaceae. Five snakes were positive at both sites tested (choana, 
cloaca) whereas nine snakes had positive results only from the choana and the remaining four only from the clo-
aca. The Chlamydiaceae-positive snakes belonged to the families Boidae (n = 6), Colubridae (n = 2), Pythonidae 
(n = 4) and Viperidae (n = 6). The majority of the snakes (n = 16) were clinically asymptomatic and sampled alive, 
whereas three samples were taken from two dead snakes at necropsy. Species-specification with the Arraymate 
microarray revealed the presence of C. pneumoniae in most samples (n = 16; 69.6%), of which one sample was 
also positive for C. muridarum. Five samples could not be further classified (21.7%), of which four were positive 
for Chlamydia sp. In addition, one sample contained C. caviae and another C. abortus. Details of Chlamydiaceae-
positive snakes are given in Table 1.
Isolation was attempted on swab samples (n = 13) from ten of the Chlamydiaceae-positive snakes. Of these, 
isolation of Chlamydia at 28 °C or 37 °C was successful in four samples from three snakes belonging to the species 
Pantheropis guttatus and Atheris squamigera. Contamination with predominantly gram-negative, rod-shaped but 
unclassified bacteria hampered the isolation process and overgrew any Chlamydia in the rest of the samples. 
Isolation was successful at 28 °C for the strains named H15-1957-3C, at 37 °C for H15-1957-10C, and at both 
temperatures for S15-834C and S15-834K.
Phenotypic characterization of field isolates from captive snakes. Growth experiments were per-
formed at 28 °C and 37 °C with and without cycloheximide for the four snake isolates, using the human C. pneu-
moniae strain K6 as a control. Initial growth curve experiments were performed using timepoints 24, 32, 40 
and 48 hpi (Supplementary Figure S1), but revealed very small inclusions at 24 hpi rendering further evaluation 
difficult. Further experiments thus used only 32 and 48 hpi. Infected monolayers were evaluated for titre and by 
IF to determine inclusion morphology and size, at 32 and 48 hpi (from early reticular body (RB) phase to mature 
inclusions). Regardless of timepoint and temperature, the C. pneumoniae strain K6, isolates H15-1957-3C and 
H15-1957-10C formed larger inclusions at earlier timepoints when cycloheximide was added (Fig. 1) as com-
pared to S15-834C and S15-834K (Fig. 2). At 37 °C, the C. pneumoniae strain K6 (Fig. 1, panel a–d), H15-1957-3C 
(Fig. 1, panel i–l) and H15-1957-10C (Fig. 1, panel q–t) formed round, regular inclusions over the course of 
48 hours. At 28 °C, inclusions remained smaller at both investigated timepoints and contained mostly RB forms 
(Fig. 1, panels e–h, m–p, u–x).
CollectionID
Snake 
no.
Sample no.1/
Strain ID Snake species
Live (L) 
Necropsy (N)
Real-time PCR 
(∅ Ct value)
Real-time PCR (∅ 
quantity, copies/µl) Arraymate Isolation
A
1 H15-1957-3C Pantherophis guttatus L 24.9 42′511 C. pneumoniae Yes
2 H15-1957-10CH15-1957-10K Atheris squamigera L
32.5
33.4
330
188
C. pneumonia
C. pneumoniae
Yes
No
B
3 H15-1971-20CH15-1971-20K
Sanzinia madagascariensis 
voluntar L
26.0
30.4
21′767
1′280
Chlamydia4
Chlamydia4
No
Not done
4 H15-1971-22CH15-1971-22K Python regius L
29.32
29.7
3′4102
2′105
C. pneumonia
C. pneumoniae
No
No
C
5 H15-2055-65K Python m. molurus L 18.4/UT3 2′354′763/UT3 C. pneumoniae Not done
6 H15-2055-69C Crotalus basilicus L 29.5 3′182 C. pneumoniae Not done
7 H15-2055-70C Crotalus basilicus L 26.9 15′388 C. pneumoniae Not done
8 H15-2055-71C Crotalus basilicus L 25.4 36′997 C. pneumoniae4 Not done
9 H15-2055-72C Crotalus basilicus L 29.2 4′206 C. pneumonia C. muridarum Not done
10 H15-2055-79CH15-2055-79K Python regius L
33.7
26.2
190
26′165
C. pneumoniae4
C. pneumoniae
Not done
Not done
D 11 H15-2833-20C Python regius L 29.5 2′547 C. pneumoniae4 Not done
E
12 H15-2898-1C Eunectes murinus L 30.9 932 Chlamydia4 No
13 H15-2898-2C Eunectes murinus L 26.5 16′134 C. pneumoniae4 No
14 H15-2898-3K Eunectes murinus L 14.1 212′659′086 Negative5 No
15 H15-2898-13C Eunectes murinus L 29.6 9′245 Chlamydia 4 No
F 16 H15-2641-14K Boa constrictor L 26.8 17′286 C. abortus No
G 17 S15-212-K Crotalus cerastes N 24.8 35′424 C. pneumoniae4 Not done
H 18 S15-834CS15-834K Pantherophis guttatus N
25.0
18.2
14′272
4′372′828
C. caviae
C. pneumoniae
Yes
Yes
Table 1. Details of snakes positive by real-time PCR for Chlamydiaceae. Samples were collected from 
asymptomatic alive snakes or taken at necropsy from dead snakes. 1C = swab samples from choana; K = swab 
sample from cloaca. 2Samples diluted 1:10 for analysis. 3UT = undetermined. 4Suspected genus/species based on 
Arraymate probes. 5Possible false-positive real-time PCR result.
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In stark contrast, isolates S15-834C and S15-834K formed inclusions of heterogeneous appearance, mostly 
elongated and growing around the host cell nucleus in a crescent-like fashion (Fig. 2). At 37 °C, they regularly 
formed loosely connected, large granular RB-like structures (Fig. 2, panel a–d, i–l), whereas at 28 °C, granular 
inclusions consisting of EBs were seen at 48 hpi (Fig. 2, panels e–h, m–p).
Inclusion size was subsequently analysed at 48 hpi and compared between isolates and temperature (n = 50 
inclusions per isolate and temperature analysed). Inclusion size for C. pneumoniae strain K6, H15-1957-3C and 
H15-1957-10C was significantly reduced at 28 °C when compared to 37 °C, with average sizes of 8.29 µm2 ± 1.48, 
Figure 1. Immunofluorescence images of C. pneumoniae K6, H15-1957-3C and H15-1957-10C at 32 
and 48 hours post infection (hpi). Shown are representative immunofluorescence images illustrating the 
morphology of C. pneumoniae K6 (a–h), H15-1957-3C (i–p), H15-1957-10C (q–x) at 32 hpi (columns 1 and 3) 
and 48 hpi (columns 2 and 4) in the presence (columns 1–2) or absence (columns 3–4) of cycloheximide. Strains 
were grown at 37 °C (top line per strain; lines 1, 3, 5) and 28 °C (bottom lane per strain; lines 2, 4, 6). The size bar 
indicates 5 µm. Chlamydial inclusions are shown in green, the LLC-MK2 nuclei (DAPI) are shown in blue.
www.nature.com/scientificreports/
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5.15 µm2 ± 0.55 and 5.15 µm2 ± 0.25 at 28 °C, and 94.19 µm2 ± 2.42, 94.09 µm2 ± 14.24 and 95.06 µm2 ± 17.11 at 
37 °C (Fig. 3a). The average size of inclusions from isolates S15-834C and S15-834K was smaller at 37 °C than at 
28 °C though the difference, while significant for S15-834K (p-value = 0.0278) was not significant for S15-834C 
(p-value = 0.0718): 34.19 µm2 ± 8.78 and 41.93 µm2 ± 3.28 at 37 °C and 71.79 µm2 ± 12.25 and 28.30 µm2 ± 0.00 
at 28 °C (Fig. 3b).
Titration by sub-passage confirmed IF observations, showing that C. pneumoniae K6, H15-1957-3C and H15-
1957-10C are significantly more infectious when grown at 37 °C compared to 28 °C. The addition of cyclohex-
imide increased the infectivity in these strains (Fig. 4a). In contrast, the infectivity of S15-834C and S15-834K 
EBs was decreased after growth at 37 °C compared to 28 °C, and cycloheximide inhibited growth of these strains 
(Fig. 4b).
TEM of all isolates was performed at 48 hpi at 28 °C and 37 °C. The snake isolates displayed inclusions at vari-
ous stages of the developmental cycle, similar in ultrastructure to C. pneumoniae strain K6 inclusions. In all four 
snake isolates, putative EBs are round, electron dense and, 0.25–0.5 nm in diameter. RBs are larger (0.5–1 mm), 
round to oval and more electron lucent. Binary fission of RBs and, occasionally, intermediate bodies (IBs, electron 
dense centre and more lucent periphery) were observed. Fully developed inclusions containing EBs, RBs and 
IBs were observed for the isolates at their respective optimum temperature, namely 37 °C for C. pneumoniae K6, 
H15-1957-3C and H15-1957-10C (Fig. 5, left panel) and 28 °C for S15-834C and S15-834K (Fig. 5, right panel). 
Interestingly, while inclusions at 28 °C resulted in small, RB-dominant inclusions for C. pneumoniae K6, H15-
1957-3C and H15-1957-10C (Fig. 5, right panel), S15-834C and S15-834K also formed 2 µm and larger sized 
RB-like structures, which were interpreted as aberrant bodies (ABs; Fig. 5, left panel).
Figure 2. Immunofluorescence images of S15-834C and S15-834K at 32 and 48 hours post infection (hpi). 
Shown are immunofluorescence images illustrating the morphology of S15-834C (a–h) and S15-834K (i–p) at 
32 hpi (columns 1 and 3) and 48 hpi (columns 2 and 4) in the presence (columns 1–2) or absence (columns 3–4) 
of cycloheximide. Strains were grown at 37 °C (top line per strain; lines 1, 3,) and 28 °C (bottom lane per strain; 
lines 2, 4,). The size bar indicates 5 µm. Chlamydial inclusions are shown in green, the LLC-MK2 nuclei (DAPI) 
are shown in blue.
www.nature.com/scientificreports/
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Antibiotic susceptibility to tetracycline, moxifloxacin and azithromycin was evaluated for the four snake iso-
lates. The control C. pneumoniae strain K6 was sensitive to all tested antimicrobial substances with MIC/MBC 
values ranging from 0.06–0.5 μg/mL (Table 2). All snake isolates were equally sensitive to tetracycline and moxi-
floxacin but showed an intermediate to resistant phenotype to azithromycin (Table 2).
Identification of the novel snake isolates. Initial identification using 16S rRNA genotype indicated 
that strains H15-1957-3C, H15-1957-10C are most closely related to C. pneumoniae (99% identity), whereas S15-
834C and S15-834K are closer to C. psittaci, C. caviae and C. abortus (99% identity to each). Due to limitations 
with the resolution of 16S rRNA gene identification, and to gain further insights into the phylogenetic position 
Figure 3. The average inclusion size of C. pneumoniae K6, H15-1957-3C and H15-1957-10C is significantly 
decreased following incubation at 28 °C compared to 37 °C. Shown is a boxplot comparing the inclusion size 
(µm2) distribution for strains a) C. pneumoniae K6, H15-1957-3C and H15-1957-10C, and b) S15-834C and 
S15-834K following 48 h of incubation at 28 °C (dark grey) or 37 °C (light grey). Filled circles represent outliers 
(>1.5x interquartile range), while asterisks represent extreme values (>3x interquartile range). The inclusion 
size was determined using a Leica DMLB fluorescence microscope (Leica Microsystems, Wetzlar, Germany) 
and a UI-2250SEC-HQ camera (uEye, IDS Imaging Development Systems GmbH, Obersulm, Germany) and 
analysed with the BonTec measuring and archiving software (BonTec, Bonn, Germany). Boxplots were created 
by the SPSS Statistics software. An unpaired t test was used for statistical analysis, and a p-value of less than 0.05 
was considered significant.
Figure 4. Titration by sub-passage confirmed that the infectivity of C. pneumoniae K6, H15-1957-3C and H15-
1957-10C is significantly higher at 37 °C while the infectivity of strains S15-834C and S15-834K is increased at 
28 °C. LLC-MK2 cells were infected with one chlamydial strain of a) either C. pneumoniae K6, H15-1957-3C, 
H15-1957-10C, or b) S15-834C, S15-834K and incubated for 48 hours at 28 °C or 37 °C in the presence (white 
bars) or absence (black bars) of cycloheximide. At 48 hours post infection, monolayers were scraped into the 
supernatant and used for titration by sub-passage. Inclusion forming units (IFU/ml) are shown in a logarithmic 
scale. Asterisks indicate statistical significance (p < 0.05) by unpaired t test.
www.nature.com/scientificreports/
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Figure 5. The ultrastructure of C. pneumoniae K6, H15-1957-3C and H15-1957-10C is similar with fully 
developed inclusions at 37 °C as opposed to 28 °C, while strains S15-834C and S15-834K form mature 
inclusions at 28 °C and show indication for the presence of aberrant bodies (ABs) at 37 °C. Cultures were fixed 
in glutaraldehyde at 48 hours post infection and processed for transmission electron microscopy. Shown is the 
ultrastructure of C. pneumoniae K6, H15-1957-3C, H15-1957-10C, S15-834C and S15-834K (top to bottom) 
following incubation at 37 °C (left column) or 28 °C (right column). The size bar indicates 10 µm. N = nucleus, 
Nc = nucleolus, Chlc = chlamydial inclusion, Cy = cytoplasm, I = intercellular space.
Isolate
Tetracycline (μg/mL) Moxiflocaxin (μg/mL) Azithromycin (μg/mL)
MIC MBC MIC MBC MIC MBC
C. pneumoniae K6 0.125–0.25 0.25–0.5 0.06–0.125 0.06–0.125 0.25 0.25
H15-1957-3C 0.5–1 1–2 0.5–1 1 2 4
H15-1957-10C 0.25–0.5 0.5 <0.06 0.06 <4 <4
S15-834C 0.25 1 <0.06 0.06 2–4 >4
S15-823K 0.25 1 <0.06 0.06 2–4 >4
Table 2. Antibiotic susceptibility testing results of the four snake isolates and the human C. pneumoniae strain 
K6. Chlamydial isolates with a MIC/MBC of 4 μg/mL were defined as resistant, whereas cultures with 2 μg/
mL ≤ MIC/MBC < 4 μg/mL were considered intermediate and isolates with a MIC/MBC of < 2 μg/mL were 
sensitive.
www.nature.com/scientificreports/
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and lifestyle of these bacteria, WGS was then performed on the strains used in the study, followed by finishing to 
generate complete chromosomes and manually improved automated annotation.
Using an established scheme based on nine conserved taxonomically informative gene products16, it was 
determined that the strains belong to two new species of the genus Chlamydia, with strains H15-1957-3C and 
H15-1957-10C most closely related to C. pneumoniae, and S15-834C and S15-834K most closely related to C. 
caviae (Fig. 6). Digital DNA-DNA hybridization (dDDH) analysis comparing their genomes to their respective 
closest relative species also indicated that these isolates represent novel species (22.6% and 30.9% respectively; 
Table 3). A scheme using pairwise comparisons of the nine gene products used above among all Chlamydia spe-
cies, also confirmed these as new species16 (Supplementary Figure S2).
These novel species were named Chlamydia serpentis (H15-1957-3C and H15-1957-10C), and Chlamydia 
poikilothermis (S15-834C and S15-834K). Careful comparisons of the genomes showed that the C. serpentis iso-
lates H15-1957-3C and H15-1957-10C are identical, and the C. poikilothermis isolates S15-834C and S15-834K 
differ only by a single base pair indel (at 32260) within an intergenic homopolymeric tract.
Whole genome characteristics of novel snake species. Features of the genomes of these novel snake 
species are given in Table 3, compared against the most closely related species, and the other sequenced species 
from a snake host, Ca. C. sanzinia14. Both novel genomes were compared to representative genomes of fifteen spe-
cies of the genus Chlamydia (Fig. 7a and b). Some regions of the chromosome exhibited lower sequence conser-
vation as compared to other Chlamydia genomes, including the PZ, pmp operons and tandem arrays of repetitive 
genes (Fig. 7). Both the new species contain plasmids.
The genome of C. serpentis isolate H15-1957-10C is syntenic with that of the comparator C. pneumoniae 
CWL029, but has many whole gene differences, the overwhelming majority of which encode hypothetical pro-
teins, including some families with Chlamydia-specific domains of unknown functions (DUF) (Supplementary 
Table S1). It also possesses fewer predicted pseudogenes than the genome of CWL02 (Table 3).
The genome of C. poikilothermis isolate S15-834K is syntenic with that of C. caviae GPIC (Fig. 8), showing 
very few whole gene differences. Most of the CDSs present in one strain and not the other encode hypothetical 
proteins (C834K_0421, 0529, 0588, 0725-7, 0729, 0816, and 0907-8; CCA_00082, 00702, 00707) and some appear 
to reflect different numbers of tandemly arranged repetitive genes (C834K_0358-60, 0596-8, 0652-6, and pmp 
genes). In addition, the genome of C. poikilothermis isolate S15-834K possesses a CDS encoding a predicted 
alpha-rhamnosidase (C834K_0688), bioB (C834K_00742), replaced by phage gene fragments in C. caviae GPIC 
(CCA_00721-2; 17), and a second CDS encoding a putative IncA homologue (C834K_0817). The CDS repre-
senting a putative non-functional invasin (CCA_00886) is absent from the genome of C. poikilothermis isolate 
S15-834K.
The genomes of the novel species C. serpentis and C. poikilothermis each contain pmp genes in four clusters 
in the same genomic locations (Fig. 8). The genome of C. pneumoniae contains the highest number of pmp gene 
copies, but also the greatest number predicted to be inactivated.
Much of the variation between strains occurs within the plasticity zone (PZ), also known as the replication 
termination region (RTR). While both the novel snake species have accBC and guaAB-add gene clusters, often 
used to describe the ends of the PZ, neither carry genes encoding cytotoxins, phospholipase D, or the tryp-
tophan operon. The C. serpentis genome of H15-1957-10C possesses a 2.5 kb putative MAC/perforin gene at 
Csp10C2_00153, and appears to have a PZ more intact than that found in the genomes of C. pneumoniae strains. 
Figure 6. Phylogeny of the genus Chlamydia including the new species. The phylogeny was reconstructed 
based on the concatenated alignment of 9 phylogenetically informative protein markers16, and includes one 
representative of each species whenever genomic data is available. Bootstrap values are shown as percentages. 
The scale bar indicates the number of amino acid substitutions per site.
www.nature.com/scientificreports/
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In comparison, the C. poikilothermis genome of S15-834K has a reduced PZ relative to that within the genome of 
C. caviae GPIC.
To rationalize the azithromycin results for the snake strains, alignments of the 23S rRNA gene were per-
formed, using sequences extracted from the genomes of S15-834K, H15-1957-10C, K6 and C. caviae GPIC. Of 
these, the former two possess intermediate resistance, and the latter two are sensitive. A single base substitution 
showing a distribution between these two groups was found, at base 1230 (AAGGAGTA/GCTGGAGC), which 
does not correlate with previous findings in which mutations at 2058 and 2059 have been implicated in conferring 
azithromycin resistance17,18.
Discussion
Evidence for the existence of two additional members of the genus Chlamydia. Analysis of four 
isolates originating from captive snakes of the species Pantherophis guttatus and Atheris squamigera has shown 
Species C. pneumoniae C. serpentis C. caviae C. poikilothermis Ca. C. sanzinia
Host Human Snake Guinea pigs Snake Snake
Disease pneumonia/bronchitis undetermined genital/ocular undetermined undetermined
Strain CWL029 H15-1957-10C GPIC S15-834K 2742-308
Accession number(s) AE001363 ERZ462351-2 AE015925-6 ERZ462353-4 CP014639
Publication Kalman NG 1999 (41) This publication Read NAR 200339 This publication Taylor-Brown BMCG14
Genome size 1230230 1198609 1173390 1155104 1113073
Predicted CDSs 1073 985 1009 979 998
Plasmid N (only in strain N16) 7533 bp 7966 bp 7559 bp 7504 bp
dDDH 22.60% 30.90%
Novel species 
probability 98.50% 100%
ANI genome 80.82% 86.01%
Virulence associated
ompA Cpn_0695 C10C_0661 CCA_00047 C834K_0054 Cs308_0329/0497
T3SS Y Y Y Y Y
tarp Cpn_0572 C10C_0530 CCA_00170 C834K_0183 Cs308_0200
tarp repeats N Y N N Y
pmp genes 22 (6 pseudogenes) 18 18 (1 pseudogene) 19 (3 pseudogenes) 19 (2 pseudogenes)
Locus_tags
Cpn_0005, 0013, 0444-7, 0451, 
0453-4, 0466-7, 0471, 0539-40, 
0963
C10C_0005,0007-8, 
0410-4, 0416, 0419-20, 
0424-7, 0495-6, 0936
CCA_00205-6, 00271-5, 00277-
84, 00624, 00806
C834K_0221-2, 0291-7, 0299, 
0302-5, 0642, 0828
Cs308_0065, 0068, 0078, 
0080, 0163-4, 0586
pmp clusters 4 4 4 4 4
bioABD Cpn_1041-4 C10C_1013-8 N - replaced by phage fragment C834K_0742 (bioB) Cs308_0663-6
udk/upp Cpn_0735 (udk) C10C_0705 (udk) N N N
incA, B, C Cpn_0186, 0585, 0291-2 C10C_0160, 0545, 0261-2 CCA_00550, 00491-0 C834K_0578, 0817, 0516-5 Cs308_0059, 0863-4
Two incA homologues Two incA homologues Two incA homologues
PZ/RTR
accBC Cpn_0182-3 C10C_0156-7 CCA_00553-4 C834K_0581-2 Cs308_0799-800
guaAB-add Cpn_0170-2 (pseudogenes) Cs0C_0149-52 CCA_00572-4 C834K_0590-2 N
cytotoxin N N CCA_00558 N N
PLD N N N N N
MAC/perforin Cpn_0176 C10C_0153 CCA_00560 (pseudogene) N N
trp operon N N CCA_00562-7 N N
Pseudogenes (curated) Cpn_0014-5 (pmp) C10C_0926 (ispE) CCA_00285 (pmpG) C834K_0289 (pmp) Cs308_0073 (pmp)
Cpn_0016-7 (pmp) CCA_00288 (gatA) C834K_0300 (pmp) Cs308_0075 (pmp)
Cpn_0018-9 (pmp) CCA_00326 (hypothetical) C834K_0310 (pmp)
Cpn_0170 (add) CCA_00515 (hypothetical) C834K_0638 (hypothetical)
Cpn_0171 (guaA) CCA_00560 (MAC/perforin) C834K_0657 (cons. hypothet)
Cpn_0267-8 (incA) CCA_00886 (invasin)
Cpn_0339-41 (recF)
Cpn_0449-50 (pmp)
Cpn_0452 (pmp)
Cpn_0470 (pmp)
Cpn_0954-5 (ispE)
Table 3. Properties of genomes of novel species compared to these of close relatives and one other species 
isolated from a snake host. T3SS: type III secretion system, PLD: Phospholipase D.
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that the criteria for assignment of two new chlamydial species within the genus Chlamydia are fulfilled. First of 
all, 16S and 23S rRNA sequence identity to members of the order Chlamydiales was ≥80%, and sequence identity 
fulfilled the assignment to the family Chlamydiaceae (16S ≥ 92.5%, 23S ≥ 91%) according to the recent classifi-
cation scheme by Pillonel et al.16. Based on the comparison of nine informative marker proteins with all other 
sequenced members of the Chlamydia genus, the new isolates can be assigned to two new species (RpoN < 96%, 
Figure 7. Circular representation of the chromosomes illustrating protein sequence conservation compared 
with other representatives of the Chlamydiaceae. The predicted CDSs are shown on the outer circle in forward 
or reverse frames. rRNA genes are shown in blue. The inner circles represent identities of the closest orthologue 
of each CDS identified using Orthofinder, compared against reference genomes. The genomes are ordered 
based on average sequence identity (see key) as below. Regions showing lower conservation are indicated. (a) 
C. serpentis H15-1957-10C: C. pneumoniae CWL029, C. poikilothermis. 834 K, C. psittaci 6BC, C. felis Fe/C-56, 
C. caviae GPIC, Ca. C. sanzinia 2742-308, C. abortus S26/3, C. pecorum E58, C. gallinacea 08–1274/3, Ca. C. 
ibidis 10–1398/6, C. muridarum Nigg, C. trachomatis D/UW-3/CX, C. avium 10DC88, C. suis MD56, Waddlia 
chondrophila WSU 86-1044. (b) C. poikilothermis S15-834K: C. psittaci 6BC, C. caviae GPIC, C. felis Fe/C-56, 
C. abortus S26/3, C. serpentis 10 C, C. pneumoniae CWL029, Ca. C. sanzinia 2742-308, C. gallinacea 08-1274/3, 
Ca. C. ibidis 10-1398/6, C. pecorum E58, C. muridarum Nigg, C. trachomatis D/UW-3/CX, C. avium 10DC88, 
C. suis MD56, Waddlia chondrophila WSU 86-1044. The two inner plots indicates the G + C content (blue for 
above average and red for below average) and G + C skew (blue for positive and green for negative).
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FtsK < 98%, PepF < 96%, Adk < 95%, HemL < 95%) of the the Chlamydia genus (DnA ≥ 70%, SucA ≥ 64%, 
Hyp325 ≥ 57% and Fabl ≥ 78%)16. Whole genome average nucleotide identity (ANI) analysis of the two new 
species with their closest relatives are also lower than the 95% generally considered to delineate bacterial species19 
(Table 3). Previously, 16S and 23S rRNA sequences20 or multilocus sequence approaches21 were used to assign 
new chlamydial species. The scheme used in this study to classify novel snake isolates is based on a set of highly 
reliable protein sequences that were shown to be good markers of whole genome relatedness16.
Comparative genomic analysis shows that C. serpentis, most closely related to C. pneumoniae, appears to have 
a less disrupted genome than the latter, having a more extensive PZ and fewer pseudogenes, perhaps therefore 
being more representative of the common ancestor of the two species. C. poikilothermis, in contrast, has a more 
reduced PZ than the closest comparator C. caviae. Comparing with the genomes of other known Chlamydia 
found in snakes14,15, none carry the cytotoxin or trp operon in the PZ, possibly implying that this improves their 
colonisation of snakes. Presence of the purine biosynthesis genes guaAB-add, however, is not required for growth 
within snakes, as this operon is absent from Ca. C. sanzinia.
Both novel species behaved intermediate to resistant to azithromycin. According to Ellington et al.22 and 
Tagini et al.23, the genotypic to phenotypic congruence for antibiotic susceptibility may vary quite extensively 
from species to species and from antibiotics to antibiotics. Thus, the fact that these new chlamydia-related spe-
cies exhibits a low susceptibility to azithromycin in absence of the typical mutations described in other species 
is somehow expected and highlights the limitation and difficulties faced when trying to infer AB susceptibility 
from genomic data.
Description of C. serpentis sp. nov. (H15-1957-10C). C. serpentis (serpentis L. fem. Gen. pl. serpentum, 
of the snake, because snakes are the currently known host).
C. serpentis strains occur in snakes belonging to the families Colubridae and Viperidae and were isolated from 
captive asymptomatic Patherophis guttatus and Atheris squamigera. The presence of the agent in other snake 
species as well as in free-ranging snakes and even other reptiles seems possible, but has yet to be investigated. C. 
serpentis can be recovered from choanal and cloacal swabs and might be also detected in inner organs of infected 
reptiles. The natural route of transmission and potential reservoirs are unknown to date. The carrier snakes were 
clinically asymptomatic, but a facultative pathogenic role has to be considered in concert with other bacterial or 
viral infections, or induced by stress due to capture and transportation, high-density farming and hibernation12. 
The potential for zoonotic infection of humans, in particular snake owners, is unknown.
C. serpentis can be grown in LLC-MK2 cells, a rhesus monkey epithelial kidney cell line, which has been 
successfully used to isolate C. suis strains from fecal swab samples24 and is able to survive and replicate at lower 
temperature such as 28 °C and 12 °C. The replication of C. serpentis is enhanced by adding cycloheximide after the 
infection to block de novo host protein synthesis similar as shown for C. pneumoniae K6. Shape, size and distribu-
tion of inclusions including their production of infectious EBs measured as IFU per mL at 32 and 48 hpi resemble 
those seen in C. pneumoniae-infected LLC-MK2 cells. Size of inclusions and productivity of C. serpentis at 28 °C 
is diminished compared to 37 °C in line with C. pneumoniae K6 in this study. By TEM, the typical bi-phasic devel-
opmental cycle can be observed for C. serpentis including EBs and RBs comparable in size and morphology to 
C. pneumoniae. C. serpentis is susceptible to tetracycline and moxifloxacin but has an intermediate sensitivity of 
azithromycin (ranging from 2 to more than 4 μg/mL). The type strain is H15-1957-10CT. Two strains H15-1957-
10C (DSM 106151) and H15-1957-3C (DSM 106152) have been deposited at the DSMZ (Deutsche Sammlung 
Figure 8. Comparison of the genomes of (top to bottom) C. pneumoniae CWL029, C. serpentis H15-1957-10C, 
C. poikilothermis S15-834K and C. caviae GPIC. Each horizontal line represents the genome, with CDSs shown 
directionally as arrow heads. Identity (tblastx) between the genomes is shown according to the scale bar. Pink 
CDSs represent pmp genes, and brown disrupted pmp genes. The genomes of S15-834K and C. caviae GPIC have 
been reverse complemented to illustrate the synteny. The plasticity zone (PZ) locus is indicated.
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von Mikrorganismen und Zellkulturen GmbH, Braunschweig, Germany) and at CSUR (Collection de Souches de 
l′ Unité Rickettsies WDCM 875, Marseille, France).
Description of C. poikilothermis sp. nov. (S15-834K). C. poikilothermis (poikilothermis adj., of a 
poikilotherm species, because this species was isolated from a poikilotherm reptile which is an organism whose 
internal temperature varies considerably).
Two highly similar strains of this species occurred in a captive Pantheropis guttatus belonging to the family 
Colubridae. The agent can be recovered from choanal and cloacal swab and is possibly also present in other 
snake families, captive or free-ranging. A pathogenic potential cannot be differentiated from the cause of death 
(salmonellosis) in the actual case. The mode of transmission and zoonotic potential are unknown. Like other 
Chlamydiaceae species, C. poikilothermis can be isolated and grown in cell culture but requires lower temperatures 
such as 28 °C. Isolation at 37 °C is less successful, growth curves (Supplementary Figure S1) over time show the 
ability of C. poikilothermis to replicate at 37 °C but inclusions are significantly smaller and morphologically sim-
ilar to ABs. The replication of C. poikilothermis is not enhanced by adding cycloheximide. It grows better in the 
absence of cycloheximide regardless of the temperature (28 °C, 37 °C). By IF, the inclusion morphology at 28 °C is 
heterogenous and inclusions tend to grow around host cell nuclei. The ultrastructural features of C. poikilothermis 
display EBs and RBs replicating by binary fission.
C. poikilothermis is susceptible to tetracycline and moxifloxacin but behaves intermediate to resistant to 
azithromycin (ranging from 2–4 μg/mL). The type strain is S15-834KT. Two strains S15-834K (DSM 106149) 
and S15-834C (DSM 106150) have been deposited at the DSMZ (Deutsche Sammlung von Mikrorganismen 
und Zellkulturen GmbH, Braunschweig, Germany) and at CSUR (Collection de Souches de l′ Unité Rickettsies 
WDCM 875, Marseille, France).
Material and Methods
Snake collections, sample collection and DNA extraction. Samples (n = 23) investigated in this 
study comprised choanal and cloacal swabs (FLOQSwabs®, Copan Italia, Brescia, Italy) taken from 18 captive 
snakes belonging to the families Boidae, Colubridae, Pythonidae and Viperidae. The majority of the snakes was 
sampled in a previous study11 and included six private snake collections in Switzerland. These snakes were clin-
ically inconspicuous at the time of sampling. Samples were collected as dry swabs for DNA extraction and sub-
sequent chlamydial screening. Chlamydia-positive snakes were sampled again, whereas swabs were stored in 
sucrose phosphate (SP) transport medium at −80 °C for isolation as described24. Additionally, two individual 
captive snakes, which had been submitted to the Institute of Veterinary Pathology (Vetsuisse Faculty, University 
of Zurich) for diagnostic purposes, were sampled during necropsy. Two swabs were collected per snake and ana-
tomical location, of which one swab was stored in SP medium.
Chlamydial screening. DNA of dry swab samples was extracted using the QIAamp DNA mini kit (Qiagen, 
Hilde, Germany), following the supplier’s recommendations. Extracted DNA of all samples (n = 23) was exam-
ined using real-time PCR based on Chlamydiaceae family-specific 23S rRNA gene primers performed on an ABI 
7500 instrument, as previously described25 including internal amplification controls26. All samples were tested in 
duplicate and the cycle threshold was set at 0.1 for each run. A mean cycle threshold (Ct value) < 38 was consid-
ered positive, and was used to calculate the corresponding chlamydial load as Chlamydiaceae 23S rRNA gene copy 
number per µl. If the amplification of internal control DNA was inhibited, the run was repeated following 1:10 
dilution of the sample. A positive control containing a sevenfold dilution series of C. abortus DNA and a negative 
control of water instead of the template DNA were included in each run27.
All samples (n = 23) were further investigated using a species-specific 23S rRNA Arraymate microarray 
assay (Alere, Jena, Germany), as established by Borel et al.28. The current version carries 34 probes for eleven 
Chlamydiaceae species, three genus-specific probes, four family markers and 15 probes for Chlamydia–like organ-
isms. Additionally, there are four internal control DNA probes and an internal staining control (biotin marker)27. 
Each sample, including internal control DNA (Intype IC-DNA, Qiagen Labor, Leipzig, Germany), was amplified 
and biotin-labeled using a biotinylation PCR, as described by Borel et al.28, with 10 minutes (min) of initialization 
(96 °C) and 40 cycles of 94 °C (denaturation), 50 °C (annealing), and 72 °C (elongation) for 30 seconds each. 2–4 µl 
of amplification product was loaded on the chip, which was processed according to manufacturer’s instructions.
Isolation of Chlamydia. Isolation from swabs in SP medium was attempted on 18 swabs from 13 snakes 
positive by chlamydial screening (Table 1) as described in Wanninger et al.24 with minor changes. Briefly, the iso-
lation process was performed in LLC-MK2 cells (continuous Rhesus monkey kidney cell line, provided by IZSLER 
Brescia, Italy) grown on glass coverslips (∅ 12 mm) in 7 ml Trac bottles (Thermo Fisher Scientific, Waltham, MA, 
USA) at 37 °C and 5% CO2. Swab samples were thawed in SP medium, vortexed with glass beads for 1 min and 
used to inoculate LLC-MK2 cells. Infected cells were then centrifuged for 3 hours (h) at 2385 g (28 °C or 33 °C) 
before incubation for 48 to 72 h at 37 °C. If enough SP material was available, incubation was additionally per-
formed at 28 °C in a second isolation attempt. Cultures were considered negative for viable Chlamydia if no inclu-
sions were detected after three passages.
Inclusion morphology and growth characteristics of novel snake chlamydiae. Isolated snake 
chlamydial strains H15-1957-3C, H15-1957-10C, S15-834C and S15-834K were further characterized in vitro 
using LLC-MK2 cells, including C. pneumoniae Kajaani 6 (K6) as a control (kindly provided by Dr Claudia 
Dumrese and Dr Urs Ziegler, Center for Microscopy and Image analysis, University of Zurich, Switzerland). 
LLC-MK2 cells, seeded at a density of 2.5 × 105 cells per well and cultivated overnight in 24-well plates in growth 
medium (500 ml Eagle’s minimum essential medium [EMEM, Gibco, Thermo Fisher Scientific, Invitrogen, 
Carlsbad, CA, USA] supplemented with 10% heat-inactivated fetal calf serum [FCS, BioConcept, Allschwil, 
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Switzerland], 5 ml L-glutamine (100x Glutamax, Gibco) and 6 ml D-(+)-glucose [0.06 g/ml, Sigma-Aldrich Co., 
St. Louis, MO, USA]), were infected with either of the five strains at multiplicity of infection (MOI) of either 0.5 
(H15-1957-3C and H15-1957-10C) or 1 (C. pneumoniae K6), or using an inoculum (S15-834C and S15-834 
K) to reach an infectivity of approximately 75% after 48 hours post infection (hpi). Incubation medium, used 
for inoculating and incubation of cells with Chlamydia, consisted of EMEM supplemented with 20% FCS, 2 g 
glucose, 5 ml L-glutamine, 4 ml Fungizone (250 µg/ml, Gibco)24. Infected monolayers were centrifuged for 1 h at 
1000 g and 25 °C. After centrifugation, inocula were replaced by fresh incubation medium with or without 1.4 μg/
ml cycloheximide (Sigma-Aldrich, St. Louis, MO, USA). Duplicate infected cultures were incubated at 28 °C and 
37 °C and 5% CO2 for 24, 32, 40 and 48 hours for preliminary evaluations. At indicated timepoints, infected cells 
were further processed for indirect immunofluorescence microscopy (IF), titre analysis and transmission electron 
microscopy (TEM).
For IF, cells were fixed with absolute methanol (−20 °C) for 10 min and chlamydial inclusions were visualized 
using a Chlamydiaceae family-specific mouse monoclonal antibody directed against the chlamydial lipopolysac-
charide (LPS, Clone ACI-P, 1:200; Progen, Heidelberg, Germany) and 1:500 diluted Alexa Fluor 488-conjugated 
secondary goat anti-mouse antibody (Molecular Probes, Eugene, OR, USA). Host and chlamydial DNA were 
labelled using 1 μg/ml 4′,6-diamidino-2′-phenylindole dihydrochloride (DAPI, Molecular Probes). Coverslips 
were mounted with FluoreGuard mounting medium (Hard Set; ScyTek Laboratories Inc., Logan, UT, USA) on 
glass slides and evaluated using a Leica DMLB fluorescence microscope (Leica Microsystems, Wetzlar, Germany) 
under oil immersion at 1000x magnification with a 10x objective (PL FLUOTAR 100x/1.30, OIL, ‘/0.17/D, 
Leica Microsystems) and a 10x ocular objective (Leica L-Plan 10x/25 M, Leica Microsystems) as described29. 
To determine the mean inclusion size, images were taken using a Leica DMLB fluorescence microscope (Leica 
Microsystems, Wetzlar, Germany) and a UI-2250SEC-HQ camera (uEye, IDS Imaging Development Systems 
GmbH, Obersulm, Germany) and analysed with the BonTec measuring and archiving software (BonTec, Bonn, 
Germany). Depending on the inclusion size, a magnification of 1000x (oil immersion) or 40x was chosen and the 
area was measured with either the “Fläche(Kreis) [Area(circle)]” or “Fläche(Polygon) [Area(polygon)]” func-
tion depending on the shape of the inclusion. The area of at least 50 inclusions was measured from one or two 
coverslips in one or two independent experiments. Boxplots were created with the SPSS Statistics software. The 
QuickCalcs unpaired t test of the GraphPad software (https://www.graphpad.com/quickcalcs/ttest1.cfm) was 
used for statistical analysis.
For titre analysis, infected monolayers were scraped into 1 ml fresh infection medium at 32 and 48 hpi. 
Supernatant and scraped cells were pooled before storage at −80 °C. Chlamydial titration by sub-passage was 
evaluated to determine the infectivity of the isolated strains at their respective optimum temperature (C. pneumo-
niae K6, H15-1957-3C and H15-1957-10C at 37 °C; S15-834C and S15-834K at 28 °C) after 48 hpi. As previously 
described24, samples were vortexed for 1 min before serial dilution in incubation medium and subsequent infec-
tion of the prepared LLC-MK2 cells was carried out as described for infection of host cells. Fixation and immu-
nostaining was performed as described for IF. The number of inclusions in 30 random microscopic fields for 
duplicate coverslips per condition was determined using a Leica fluorescence micro- scope at 200x magnification 
with a 20x objective (PL FLUOTAR 20x/0.50 PH 2, ‘/0.17/B) and a 10x ocular objective (Leica L-Plan 10x/25 M, 
Leica Microsystems). Inclusion forming units (IFU) per ml of undiluted inoculum was then calculated.
For TEM analysis, cells were fixed with 2.5% glutaraldehyde (Electron Microscopy Sciences, Ft. Washington, 
USA) for 1 h and embedded in epoxy resin (Fluka; Sigma-Aldrich).
Antibiotic susceptibility testing. Antibiotic susceptibility testing of the four snake isolates (H15-1957-3C, 
H15-1957-10C, S15-834C and S15-834K) and the human C. pneumoniae isolate K6 was performed as described 
previously24,30. Antimicrobial drugs included tetracycline (Sigma-Aldrich), moxifloxacin (Sigma-Aldrich) and 
azithromycin (Sigma-Aldrich).
Briefly, we collected chlamydiae-positive cultures in SP media and determined the number of inclusion form-
ing units per ml (IFU/ml) via 10-fold dilution as described24,30 Each antibiotic susceptibility determination was 
performed with approximately 5 × 103 IFU/mL per investigated isolate30,31. Following inoculation of sixteen 
confluent monolayers and centrifugation (1 h, 2385 g, 33 °C), inocula were replaced with incubation medium 
containing a serial two-fold dilution of the antimicrobial agent in question. After a 48-hour incubation period 
at their optimum temperature (28 °C or 37 °C), monolayers were fixed in methanol for 10 min, immunolabelled 
and processed with a fluorescein-conjugated monoclonal antibody specific for the chlamydial LPS genus-specific 
antigen (IMAGEN Chlamydia K610111–2, Thermo Fisher Scientific) as described24.
The minimum inhibitory concentration (MIC) of the respective antibiotic substance was defined as “the low-
est concentration preventing the detection of more than 90% of the chlamydial inclusions compared with the 
drug-free control”30,31. In parallel, media of the remaining Trac bottles was replaced with antibiotic-free chlamy-
diae cultivation medium after washing the coverslips with PBS. Monolayers were fixed after 48 h of incubation 
and immunolabelled for the evaluation of the minimum bactericidal concentration (MBC), which was identical 
to MIC determination. Chlamydial isolates with an MIC/MBC of 4 μg/mL were defined as resistant, whereas 
cultures with 2 μg/mL ≤ MIC/MBC < 4 μg/mL were considered intermediate, and isolates with a MIC/MBC of 
<2 μg/mL sensitive.
Identification using 16S rRNA gene analysis. Initial genotyping was performed by sequencing the 
16S rRNA gene using the Chlamydiales-specific primer pair 16SIGF (5′- CGGCGTGGATGAGGCAT-3′) and 
16SB1 (5′-TACGGYTACCTTGTTACGACTT-3′)32 targeting almost the entire gene (approximately 1400 bp) as 
described11. PCR products were purified with the QIAquick PCR Purification Kit (Qiagen) according to manufac-
turer’s instructions. Purified DNA was Sanger sequenced by Microsynth (Balgach, Switzerland).
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WGS, mapping, assembly and annotation. Sequencing of the four snake isolates (H15-1957-3C, 
H15-1957-10C, S15-834C and S15-834K) and the human C. pneumoniae isolate K6 was performed on the 
Illumina Miseq platform with 250 bp paired end reads at the Functional Genomics Center Zurich (FGCZ), 
following NEBNext library creation. Coverage data is shown in Supplementary Table S2. Assembly was per-
formed using SPAdes in multi-cell mode33, followed by ordering of the chlamydial contigs against C. pneu-
moniae CWL029 (accession number AE001363) or C. psittaci 01DC12 (HF545614) within ACT34. The contig 
order was confirmed, and genomes finished, by amplifying and capillary sequencing across gaps using the prim-
ers listed in Supplementary Table S3. The resulting single contig genome assemblies were checked and com-
pared using BWA35. The genome of K6 remained in two contigs. Automated annotation was performed using 
AnnotateBacteria [https://github.com/sanger-pathogens/Bio-AutomatedAnnotation/] with further manual cura-
tion in Artemis34,36. All read data, with associated assembly and annotation where relevant, has been submitted 
to ENA under project PRJEB19768.
Phylogenetic and genome analysis. Average nucleotide identity (ANI) determination was performed 
at enve-omics.ce.gatech.edu/ani/19 and digital DNA-DNA hybridisation (dDDH) using GGDC2.1 (ggdc.dsmz.
de/distalcalc2.php) and the DDH cut off of ≤70%37. Comparator genomes used were C. pneumoniae CWL029 
(accession number AE001363)38 and C. caviae GPIC (AE015925)39. Comparisons were performed using tblastx, 
visualized in ACT, to identify novel and duplicated genes.
Nine phylogenetically informative markers were identified with hmmsearch v3.1 (http://journals.plos.org/
ploscompbiol/article?id=10.1371/journal.pcbi.1002195) using hmm profiles built from 21 reference sequences16. 
Amino acid sequences were aligned with mafft (parameters:–auto–maxiterate 1000). Alignments were concat-
enated to build a reference phylogeny using Phyml v 3.1 (https://www.ncbi.nlm.nih.gov/pubmed/20525638), 
with the LG + Г + I model and 100 bootstrap replicates. Pairwise amino acid sequence identities were calcu-
lated based on pairwise Needleman-Wunsch global alignments (EMBOSS:6.6, https://www.ncbi.nlm.nih.gov/
pubmed/10827456). Amino acid sequences of predicted coding sequences were clustered into orthologous groups 
with Orthofinder v. 0.4 (https://genomebiology.biomedcentral.com/articles/10.1186/s13059–015–0721–2).
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